CKC new best logo_cropped_JPEG.jpg
Cross Keys Capital Advises Rockland Retina on Its Sale to Retina Consultants of America
September 21, 2021 09:00 ET | Cross Keys Capital, LLC.
Fort Lauderdale, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Cross Keys Capital served as the exclusive sell-side M&A advisor to Rockland Retina (RR) in its partnership with Retina Consultants of America...
Insights on the Ophthalmic Drug Delivery Devices Global Market to 2030 - Featuring Nipro, Teruo and West Pharmaceutical Services Among Others
September 15, 2021 06:13 ET | Research and Markets
Dublin, Sept. 15, 2021 (GLOBE NEWSWIRE) -- The "Global Ophthalmic Drug Delivery Devices Market: Focus on Product, Formulation, Sales Channel, End User, and 21 Countries - Analysis and Forecast,...
Global Dry Eye Medication Market Research Report 2021
July 15, 2021 08:08 ET | Research and Markets
Dublin, July 15, 2021 (GLOBE NEWSWIRE) -- The "Dry Eye Medication Global Market Opportunities and Strategies to 2030: COVID-19 Impact and Recovery" report has been added to's...
Outlook on the Artificial Tears Global Market to 2028 - by Type, Delivery Mode, Application and Geography
July 12, 2021 05:13 ET | Research and Markets
Dublin, July 12, 2021 (GLOBE NEWSWIRE) -- The "Artificial Tears Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Type, Delivery Mode, and Application" report has been added to...
Midwest Vision Partners Selects Nextech’s IntelleChartPRO
July 06, 2021 13:30 ET | Nextech Systems, Inc.
TAMPA, Fla., July 06, 2021 (GLOBE NEWSWIRE) -- Nextech Systems, a leading provider of healthcare technology solutions for specialty providers, today announced a new partnership with Midwest Vision...
Global Eye Care Market (2020 to 2026) - by Product Type, Eye Drops, Coating, Lens Material, Distribution Channel and Region
July 02, 2021 04:18 ET | Research and Markets
Dublin, July 02, 2021 (GLOBE NEWSWIRE) -- The "Global Eye Care Market, By Product Type (Eyeglasses, Eye Drops, Contact Lens, Intraocular Lens, Eye Vitamins, Others), By Eye Drops (Prescription v/s...
NOVARTIS logo.jpg
Novartis reports one year results of Phase III MERLIN study evaluating Beovu® every four week dosing and provides update on Beovu clinical program
May 28, 2021 16:30 ET | Novartis Pharma AG
Beovu (brolucizumab) met MERLIN’s primary endpoint of non-inferiority in change in best corrected visual acuity from baseline and superiority on anatomical secondary endpoints at year one versus...
Worldwide Veterinary Eye Care Industry to 2026 - Increasing Burden of Eye Diseases in Animals is Driving Growth
May 10, 2021 08:53 ET | Research and Markets
Dublin, May 10, 2021 (GLOBE NEWSWIRE) -- The "Veterinary Eye Care Market - Growth, Trends, and Forecasts (2021 - 2026)" report has been added to's offering. Veterinary Eye...
NOVARTIS logo.jpg
Novartis Phase III Beovu® data show potential for fluid resolution in more diabetic macular edema patients with fewer injections versus aflibercept
May 01, 2021 07:05 ET | Novartis Pharma AG
In KESTREL and KITE, Beovu (brolucizumab) 6 mg met the primary endpoints of non-inferiority in change in best corrected visual acuity from baseline versus aflibercept 2 mg at year one in diabetic...
Outlook on the Dry Eye Disease (DED) Global Market to 2026 - Featuring Johnson & Johnson, Bausch Health and Alcon Among Others
April 29, 2021 05:13 ET | Research and Markets
Dublin, April 29, 2021 (GLOBE NEWSWIRE) -- The "Global Dry Eye Disease (DED) Market - Analysis By Disease (Aqueous, Evaporative, Others), Treatment, End User, Distribution Channel, By Region, By...